본문 바로가기
KERD
논문KCI 등재후보

Standardized protocol of blood pressure measurement and quality control program for the Korea National Health and Nutrition Examination Survey

0

조회

0

다운로드

3

인용

0

참고문헌

키워드

초록

Accurate blood pressure (BP) measurement is crucial for hypertension detection and management. The Korea National Health and Nutrition Examination Survey (KNHANES) assesses the health of Koreans using representative cross-sectional data. BP measurements were historically done with mercury sphygmomanometers for participants aged ≥10 years. However, KNHANES transitioned to Greenlight 300TM (mercury-free auscultatory device) in 2020 for participants aged ≥6 years and used dual devices (Microlife WatchBP Office AFIB and Greenlight) in 2021-2022. To ensure consistency, KNHANES will adopt Microlife as the unified BP device with Greenlight for device validation from 2023. Under the new protocol, participants aged ≥6 years will have their BP measured three times at 30-second intervals after a 5-minute rest under ambient temperature (20-25℃) and noise ≤65 dB. The average of the 2nd and 3rd readings will be used as the representative BP value. The quality control (QC) program involves four trained examiners passing the “quality control and assurance of BP measurement program” three times annually, and undergoing “video monitoring of weekly calibration process” once a year. Additionally, the QC team will conduct “on-site evaluations of BP measurement” at mobile examination centers three times a year. A Five-Step QC process for BP devices was also developed. This document outlines the standardized BP measurement protocol and rigorous QC program in KNHANES, aiming to ensure accurate and reliable BP data for epidemiological research and public health policymaking in South Korea.

Abstract

Accurate blood pressure (BP) measurement is crucial for hypertension detection and management. The Korea National Health and Nutrition Examination Survey (KNHANES) assesses the health of Koreans using representative cross-sectional data. BP measurements were historically done with mercury sphygmomanometers for participants aged ≥10 years. However, KNHANES transitioned to Greenlight 300TM (mercury-free auscultatory device) in 2020 for participants aged ≥6 years and used dual devices (Microlife WatchBP Office AFIB and Greenlight) in 2021-2022. To ensure consistency, KNHANES will adopt Microlife as the unified BP device with Greenlight for device validation from 2023. Under the new protocol, participants aged ≥6 years will have their BP measured three times at 30-second intervals after a 5-minute rest under ambient temperature (20-25℃) and noise ≤65 dB. The average of the 2nd and 3rd readings will be used as the representative BP value. The quality control (QC) program involves four trained examiners passing the “quality control and assurance of BP measurement program” three times annually, and undergoing “video monitoring of weekly calibration process” once a year. Additionally, the QC team will conduct “on-site evaluations of BP measurement” at mobile examination centers three times a year. A Five-Step QC process for BP devices was also developed. This document outlines the standardized BP measurement protocol and rigorous QC program in KNHANES, aiming to ensure accurate and reliable BP data for epidemiological research and public health policymaking in South Korea.

참고문헌 (30)

  1. Kim Hyeon Chang, "Korea hypertension fact sheet 2022: analysis of nationwide population-based data with a special focus on hypertension in the elderly", Clinical Hypertension, 29, pp.22~22 (2023), 대한고혈압학회[DOI]
  2. 오경원, "Korea National Health and Nutrition Examination Survey, 20th Anniversary: Accomplishments and future directions", Epidemiology and Health, 43, pp.1~10 (2021), 한국역학회[DOI]
  3. Kweon S, "Data resource profile : the Korea national health and nutrition examination survey(KNHANES)", Int J Epidemiol, 43, pp.69~77 (2014)
  4. Tolonen H, "Challenges in standardization of blood pressure measurement at the population level", BMC Med Res Methodol, 15, pp.1~11 (2015)
  5. Graciani A, "Assessment of a blood pressure measurement training programme for lay observers", Blood Press Monit, 7, pp.251~257 (2002)
  6. "Mercury sphygmomanometers in healthcare and the feasibility of alternatives" (2009)[URL]
  7. Choi S, "Comparison of the accuracy and errors of blood pressure measured by 2 types of nonmercury sphygmomanometers in an epidemiological survey", Medicine, 97, pp.e10851~ (2018)
  8. Stergiou GS, "A universal standard for the validation of blood pressure measuring devices : Association for the Advancement of Medical Instrumentation", European Society of Hypertension, ESH, pp.ISO)Collaboration Statement, Hypertension[DOI]
  9. Kim YM, "Direct comparison of an automated oscillometric device with an electronic auscultatory device for epidemiologic survey to evaluate the prevalence of hypertension", Medicine, 101, pp.e32299~ (2022)
  10. Lee EM, "Comparative assessment between automated devices and a non-mercury auscultatory device in the Korea National Health and Nutritional Examination Survey", Weekly Health and Disease: Korea Disease Control and Prevention Agency, pp.96~103 (2021)[DOI]
  11. Quality Control and Assurance of Blood Pressure Measurement-Korea National Health and Nutrition Examination Survey 2019, "Lee EM", Korea Centers for Disease Control and Prevention, 1~231 (2020)
  12. Quality Control and Assurance of Blood Pressure Measurement - Korea National Health and Nutrition Examination Survey 2021, "Lee EM", Korea Centers for Disease Control and Prevention, 1~427 (2021)
  13. Flynn JT, "New clinical practice guideline for the management of high blood pressure in children and adolescents", Hypertension, 70, pp.683~686 (2017)
  14. Lurbe E, "2016 European Society of Hypertension guidelines for the management of high blood pressure in children and adolescents", J Hypertens, 34, pp.1887~1920 (2016)
  15. Quality Control and Assurance of Blood Pressure Measurement-Korea National Health and Nutrition Examination Survey 2022, "Lee EM", Korea Centers for Disease Control and Prevention, 1~448 (2023)
  16. "WatchBP Office"[URL]
  17. Kollias A, "Validation of the professional device for blood pressure measurement Microlife WatchBP Office in adults and children according to the American National Standards Institute", Association for the Advancement of Medical Instrumentation, Blood Press Monit, pp.2018, 23[DOI]
  18. Frick G, "Declaration of blood pressure measuring device equivalence 2006", Microlife WatchBP Office Afib (TWIN200 AFS), 1~ (2006)
  19. Palatini P, "Accuracy of the WatchBP office ABI device for office blood pressure measurement over a wide range of arm sizes", Blood Press Monit, 23, pp.117~119 (2018)
  20. Wiesel J, "Detection of atrial fibrillation using a modified microlife blood pressure monitor", Am J Hypertens, 22, pp.848~852 (2009)
  21. Ogedegbe G, "Principles and techniques of blood pressure measurement", Cardiol Clin, 28, pp.571~586 (2010)
  22. van Popele NM, "Arterial stiffness as underlying mechanism of disagreement between an oscillometric blood pressure monitor and a sphygmomanometer", Hypertension, 36, pp.484~488 (2000)
  23. Chan PH, "Diagnostic performance of an automatic blood pressure measurement device, Microlife WatchBP Home A, for atrial fibrillation screening in a real-world primary care setting", BMJ Open, 7, pp.e013685~ (2017)
  24. Muntner P, "Measurement of Blood Pressure in Humans : A Scientific Statement From the American Heart Association", Hypertension, 73, pp.e35~e66 (2019)
  25. Maxwell M, "Error in blood-pressure measurement due to incorrect cuff size in obese patients", Lancet, 320, pp.33~36 (1982)
  26. Sprafka JM, "The effect of cuff size on blood pressure measurement in adults", Epidemiology, 2, pp.214~217 (1991)
  27. Graves JW, "The Accoson Greenlight 300, the first non-automated mercury-free blood pressure measurement device to pass the International Protocol for blood pressure measuring devices in adults", Blood Press Monit, 9, pp.13~17 (2004)
  28. O’Brien E, "Training and assessment of observers for blood pressure measurement in hypertension research", J Hu Hypertens, 5, pp.7~10 (1991)
  29. O’Brien E, "An outline of the revised British Hypertension Society protocol for the evaluation of blood pressure measuring devices", J Hypertens, 11, pp.677~679 (1993)
  30. Gigal Medical, "RIGEL BP-SIM, Hand-held NIBP simulator. Intruction Manual", 1~70 (2013)

관련 논문AI추천

Trends in Blood Pressure and Prevalence of Hypertension in Korean Adults Based on the 1998–2014 KNHANES강희택, 김예슬, 김진영, 김태종, 배장환, 이상현, 이용재, 이재우, 인요한, 임형지, 조명찬연세대학교의과대학 · Yonsei Medical Journal2018 · 제59권 제3호2013 Korean Society of Hypertension guidelines for the management of hypertension. Part I—epidemiology and diagnosis of hypertension김광일, 김권호, 김영권, 김주한, 박정배, 변욱범, 신진호, 양동현, 채성철, 대한고혈압학회대한고혈압학회 · Clinical Hypertension2015 · 제21권 제1호오므론 HEM 907 XL 자동 진동식 혈압계와 수동 수은혈압계의 오차에 미치는 연령의 영향김기혁, 김남수, 문진수, 박지원, 이종국대한고혈압학회 · Clinical Hypertension2011 · 제17권 제3호Diagnostic accuracy of manual office blood pressure measurement in ambulatory hypertensive patients in KoreaChang-Hwan Yoon, Dong-Ju Choi, Doo Ryeon Chung, Goo-Yeong Cho, Hae-Young Lee, Il-Young Oh, In Ho Chae, Jinho Shin, Jin Joo Park, Jung-Won Suh, Sehun Kim, Seung-Ah Lee, Sungha Park, Yeonyee E. Yoon, Youngjin Cho, Young-Seok Cho대한내과학회 · The Korean Journal of Internal Medicine2018 · 제33권 제1호Smartphone / smartwatch-based cuffless blood pressure measurement : a position paper from the Korean Society of Hypertension김광일, 김대희, 김주한, 김현창, 박성하, 서종모, 성기철, 손일석, 신진호, 유승기, 이해영, 임상현, 정욱진, 조은주, 편욱범, Lee Dong-Ju대한고혈압학회 · Clinical Hypertension2021 · 제27권 제2호Home blood pressure monitoring: a position statement from the Korean Society of Hypertension Home Blood Pressure Forum김광일, 김주한, 김철호, 박성하, 박재형, 신진호, 이은미, 이해영, 임상현, Kim Jang Young대한고혈압학회 · Clinical Hypertension2022 · 제28권

이 간행물의 다른 논문 (32건)